R. Favre
发表
J. Cano,
J. Rigault,
S. Monjanel,
2004,
Cancer Chemotherapy and Pharmacology.
E. Bingen,
D. Hocquet,
P. Mariani-Kurkdjian,
2007,
Antimicrobial Agents and Chemotherapy.
P. Hérait,
G. Deplanque,
J. Bereder,
2004
.
P. Hérait,
G. Deplanque,
J. Bereder,
2004,
Annals of oncology : official journal of the European Society for Medical Oncology.
C. Tournigand,
E. Raymond,
A. Gramont,
1997,
Cancer.
Disclosure of prognosis to terminally ill patients: attitudes and practices among French physicians.
J. Moatti,
A. Galinier,
M. Bendiane,
2005,
Journal of palliative medicine.
B. Lacarelle,
P. Guillet,
F. Duffaud,
1997,
Cancer Chemotherapy and Pharmacology.
A. Borg,
P. Gallice,
R. Favre,
1996,
Cancer research.
B. Lacarelle,
P. Guillet,
F. Duffaud,
1995,
Therapeutic drug monitoring.
J. Vion-Dury,
S. Confort-Gouny,
P. Cozzone,
1991
.
P. Gallice,
R. Favre,
A. Crevat,
1998,
Oncology Research.
P. Auquier,
S. Salas,
R. Bensadoun,
2009,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
A. Iliadis,
J. Cano,
A. Durand,
2004,
Cancer Chemotherapy and Pharmacology.
S. Salas,
B. Lacarelle,
J. Ciccolini,
2006,
Therapeutic drug monitoring.
A. Iliadis,
R. Bruno,
J. Cano,
1985,
Cancer drug delivery.
J. Seitz,
D. Raccah,
B. Vialettes,
2008,
Diabetes & metabolism.
B. Lacarelle,
J. Seitz,
J. Ciccolini,
2010,
Cancer Chemotherapy and Pharmacology.
J. Moatti,
A. Galinier,
M. Bendiane,
2003,
Journal of palliative care.
D. Olive,
J. Gabert,
D. Blaise,
1990
.
M. Baciuchka,
B. Sastre,
F. Garrouste,
1998,
International journal of cancer.
J. Barbet,
A. Iliadis,
R. Rahmani,
1987,
Cancer research.
A. Galinier,
M. Bendiane,
P. Peretti-Watel,
2008,
Journal of critical care.
M. Baciuchka,
B. Lacarelle,
P. Guillet,
2006,
Therapeutic drug monitoring.
J. Moatti,
A. Galinier,
M. Bendiane,
2003,
BMJ : British Medical Journal.
A. Galinier,
M. Bendiane,
P. Peretti-Watel,
2004,
AIDS care.
A. Galinier,
M. Bendiane,
A. Bouhnik,
2009,
Journal of Medical Ethics.
J. Ciccolini,
F. Duffaud,
A. Durand,
2002,
Therapeutic drug monitoring.
M. Mattéi,
T. Orsière,
F. Duffaud,
1999,
Environmental and molecular mutagenesis.
J. Gastaut,
Y. Carcassonne,
R. Favre,
1982,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
J. Cano,
Y. Carcassonne,
R. Favre,
2004,
Cancer Chemotherapy and Pharmacology.
S. Clément,
J. Cano,
M. Alfonsi,
1982,
Cancer Chemotherapy and Pharmacology.
Y. Carcassonne,
R. Favre,
T. Pignon,
1984,
Pathologie-biologie.
X. J. Zhou,
R. Rahmani,
S. Monjanel,
2004,
Cancer Chemotherapy and Pharmacology.
X. J. Zhou,
R. Rahmani,
R. Favre,
1994,
Biopharmaceutics & drug disposition.
Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients.
T. Orsière,
F. Duffaud,
M. de Meo,
2002,
Mutation research.
Roch Giorgi,
S. Salas,
M. Zanaret,
2008,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
A. Iliadis,
R. Bruno,
R. Favre,
1985,
Journal of Pharmacokinetics and Biopharmaceutics.
J. Cano,
Y. Carcassonne,
R. Favre,
2004,
Cancer Chemotherapy and Pharmacology.
A. Iliadis,
J. Cano,
A. Durand,
1982,
Bulletin du cancer.
F. Volot,
F. Duffaud,
L. Digue,
2003,
European journal of cancer.
L. Garbe,
F. Duffaud,
L. Digue,
2000,
Cancer.
D. Olive,
D. Blaise,
C. Bressac,
1992,
Journal of immunotherapy.
G. Salles,
L. Baseggio,
E. Callet‐Bauchu,
2018,
International journal of laboratory hematology.
L. Matherly,
J. Cano,
G. Fabre,
1983,
Cancer research.
J. Barbet,
R. Rahmani,
J. Cano,
1984,
European journal of cancer & clinical oncology.
R. Favre,
A. Durand,
B. Lacarelle,
2004,
Journal of clinical pharmacy and therapeutics.
A. Iliadis,
J. Ciccolini,
F. Duffaud,
2008,
Anti-cancer drugs.
S. Salas,
G. Milano,
F. Franceschini,
2007,
Pharmacogenetics and genomics.
J. Cano,
Y. Carcassonne,
R. Favre,
1987,
European journal of cancer & clinical oncology.
R. Bruno,
J. Cano,
R. Favre,
1987,
European journal of cancer & clinical oncology.
J. Ciccolini,
F. Duffaud,
A. Durand,
2003,
Journal of clinical pharmacy and therapeutics.
A. Galinier,
M. Bendiane,
P. Peretti-Watel,
2007,
Journal of Medical Ethics.
R. Favre,
J. Vion-Dury,
S. Confort-Gouny,
1993,
NMR in biomedicine.
T. Orsière,
F. Volot,
F. Duffaud,
1999,
Mutation research.
B. Lacarelle,
P. Guillet,
F. Duffaud,
2004,
Cancer Chemotherapy and Pharmacology.
S. Salas,
L. Dany,
P. Cannone,
2004,
Bulletin du cancer.
L. Dany,
R. Favre,
É. Dudoit,
2008
.
A. Iliadis,
J. Cano,
Y. Carcassonne,
1988,
Bulletin du cancer.
G. Milano,
B. Lacarelle,
J. Seitz,
2006,
Therapeutic drug monitoring.
J. Vion-Dury,
S. Confort-Gouny,
P. Cozzone,
1993,
Journal of lipid research.
A. Galinier,
P. Peretti-Watel,
Y. Obadia,
2003,
Annales de medecine interne.
D. Spaeth,
D. Cupissol,
M. Fabbro,
1996
.
P. Auquier,
F. Barlesi,
F. Duffaud,
2004,
Presse medicale.
Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients.
T. Orsière,
F. Volot,
F. Duffaud,
1997,
Mutagenesis.
A. Galinier,
P. Peretti-Watel,
Y. Obadia,
2003,
Presse medicale.
A. Galinier,
M. Bendiane,
P. Peretti-Watel,
2005,
Journal of opioid management.
M. Baciuchka,
F. Garrouste,
M. Remacle-Bonnet,
1998,
International journal of cancer.
Y. Carcassonne,
R. Favre,
G. Meyer,
1975,
British Journal of Cancer.
J. Moatti,
M. Bendiane,
P. Peretti-Watel,
2003,
Palliative and Supportive Care.
J. Rigault,
S. Monjanel,
Y. Carcassonne,
2004,
Cancer Chemotherapy and Pharmacology.
B. La Scola,
F. Duffaud,
A. Boulamery-Velly,
2004,
The Journal of hospital infection.